PATENT CLAIM ANALYSIS

Application Number: 15767146
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "019300"]

Abstract:
Provided is a nRGD polypeptide formed by connecting alanine-alanine-asparagine (AAN) and a polypeptide containing arginine-glycine-aspartic acid (RGD), wherein the nRGD polypeptide can target tumour vessels, tumour cells and tumour-associated macrophages, and mediate the targeted delivery of tumours.

Claim (Index 4):
The polypeptide nRGD according to  claim 3 , wherein the AAN-containing sequence is preferably covalently linked to the RGD-containing peptide.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 91.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15523188', '12821050', '14655869', '15798287', '15495474']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7446099942830141
- 35 USC 102 Novelty (BERT): 0.5056218981034201
- Combined Prediction Score: 0.7207111846650547
- Mean Citation Score: 221.6582
- Max Citation Score: 234.30235
- Similarity Product: 153.593023846215

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test